Funding

Dr. Lerman's lab is supported by grants from the National Institutes of Health (NIH) and other extramural sources, which fund several research projects related to renal and cardiovascular physiology and pathophysiology. Dr. Lerman also mentors other principal investigators on their NIH-funded research projects.

Investigator & Role	Grant Title	Funding Source	Duration
Lilach O. Lerman, M.D., Ph.D., principal investigator	Quantitative magnetization transfer MRI for evaluation of renal fibrosis	NIH, R01DK122734	03/15/2020-01/31/2024
Lilach O. Lerman, M.D., Ph.D., principal investigator	Obesity-induced mesenchymal stem cell senescence	NIH, R01 DK120292	12/27/2018-11/30/2022
Lilach O. Lerman, M.D., Ph.D., principal investigator	Noninvasive evaluation of renal allograft fibrosis by MRI	NIH, R21AG 62104	06/15/2020-03/31/2022
Xiangyang Zhu, M.D., Ph.D., principal investigator; Lilach O. Lerman, M.D., Ph.D., mentor	Delivery of VEGF mRNA in a porcine model of renal artery stenosis	Astra Zeneca Pharmaceuticals	07/17/2020-07/16/2022
Sabena M. Conley, Ph.D., principal investigator; Lilach O. Lerman, M.D., Ph.D., mentor	Mesenchymal stem cell senescence in obesity	Burroughs Wellcome Fund, 1018672	09/01/2018-08/31/2021
Sandra M. Herrmann, M.D., principal investigator; Lilach O. Lerman, M.D., Ph.D., mentor	Hypoxic preconditioning for the improvement of the regenerative capacity of adipose-derived mesenchymal stem cells and its application in chronic kidney disease due to hypertensive nephropathy	NIH, K08 DK118120-01	07/01/2018-05/31/2023
LaTonya J. Hickson, M.D., principal investigator; Lilach O. Lerman, M.D., Ph.D., mentor	Mesenchymal stem cell senescence in diabetic nephropathy	NIH, K23DK109134	07/01/2016-04/30/2021